Medical innovation is advancing at an unprecedented pace, yet access to these breakthroughs remains deeply unequal. From who is represented in clinical trials, to who benefits from emerging therapies, data-driven tools, and workforce opportunities, inequity continues to shape outcomes long before a product ever reaches the market.
In this one-hour session, part of the CIC Midday Mindshare Series, we will explore how equity must be intentionally designed into the future of medical innovation, not as an afterthought, but as a core operating principle.